Langhorne, PA, United States of America

Rong Feng

USPTO Granted Patents = 13 

 

 

Average Co-Inventor Count = 6.1

ph-index = 3

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Rong Feng: Innovator in Pharmaceutical Peptide Purification

Introduction

Rong Feng, an accomplished inventor based in Langhorne, PA, has made significant contributions to the field of pharmaceutical innovations. With a prolific portfolio of 13 patents, he has been at the forefront of inventing processes that enhance the efficacy and purity of pharmaceutical compounds.

Latest Patents

Among his most recent inventions are the patents for "Ultra-pure agonists of guanylate cyclase C, method of making and using same". This invention describes innovative processes for purifying a peptide that includes a guanylate cyclase C (GCC) agonist sequence. Specifically, the processes involve a solvent exchange step followed by a freeze-drying (lyophilization) step, which significantly enhances the purity of the resultant compounds. These breakthroughs have important implications for pharmaceutical applications.

Career Highlights

Rong has demonstrated exceptional expertise throughout his career, working with notable companies such as Synergy Pharmaceuticals, Inc. and Bausch Health Ireland Limited. His experience in these leading pharmaceutical firms has provided a solid foundation for his inventive endeavors.

Collaborations

Throughout his career, Rong Feng has collaborated with talented professionals, including Kumwar Shailubhai and Stephen Comiskey. These partnerships have allowed for a rich exchange of ideas and furthered the development of innovative solutions in the field of peptide purification.

Conclusion

Rong Feng's contributions to the pharmaceutical industry through his inventions underline the importance of innovation in improving drug efficacy. With a solid track record of patents and collaborations, he continues to inspire future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…